Amyloidosis Treatment Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 40729 Report Format: PDF + Excel (Delivery in 48 Hrs)

Overview

Amyloidosis Treatment Market is projected to reach revenue of $6.7 billion by 2025, and is estimated to grow at a CAGR of 7.1% during the forecast period 2019-2025. The Amyloidosis Treatment market size, in 2018, is said to be $4.13 billion. Amyloidosis Treatments are used to reduce the symptoms of amyloidosis and limit production of amyloid protein. It may due to various causes such as bone marrow disorder, hereditary factors, or even due to some other underlying illness. Such amyloid deposition leads to organ failure.


Key Takeaways

  • The market is estimated to grow at a CAGR of 7.1% owing to the rising prevalence of the disease among geriatric population.
  • Companies are adopting various strategic alliances to expand in various regions. Investments in research have increased in order to develop treatment drugs for amyloidosis.
  • Amyloidosis is of various types such as AA (Amyloid A), AL (Amyloid light chain), ATTR (Amyloid transthyretin) or transthyretin amyloidosis, and others.

Treatment - Segment Analysis

By treatment, chemotherapy is the major segment in this market with CAGR of 5.2%. This is because, it is one of the most effective forms of treatment opted for by many patients. Chemotherapy is usually administered by an intravenous tube or orally as a drug. Targeted therapy will have a higher growth rate in the coming years. Targeted therapies include, anti-angiogenesis therapy, monoclonal antibodies, and proteasome inhibitors.

Geography - Segment Analysis

North America is dominant in the market by geography and holds 35% of the Amyloidosis Treatment market share. This is owing to the release of pipeline drugs here, advanced treatment opportunities for people and the health care facilities availability here.

Drivers – Amyloidosis Treatment Market

·         Growing geriatric population and prevalence of amyloidosis in them

As per statistics on the American Society of Clinical Oncology, around 4000 people in U.S. develop amyloidosis each year and it is typically diagnosed among people aged 50-65 years. There are only a few cases of people in their late 20s being diagnosed with amyloidosis. Thus with a rise in elderly population, the amyloidosis treatment market will also grow.

·         Favorable investments in different countries

The governments of various countries are investing in their research & development for drugs and other treatment methods for amyloidosis. Some developed economies have advanced medical treatments and technologically advances diagnostics also. Thus with increased support from government or other authorizing bodies, the market in such regions will flourish.

Challenges – Amyloidosis Treatment Market

·         High cost of treatment and limited awareness

In some developing or underdeveloped nations, the market for amyloidosis will be constrained due to higher costs of healthcare as well as the limited awareness among the people here. However, government initiatives are increasing in such regions and these markets are said to have prospective growth.

Amyloidosis Treatment Industry Outlook

Research & development along with strategic alliances are some of the key strategies adopted by players in the Amylodosis Treatment market. Amylodosis Treatment Market top 10 companies are Prothena Corporation plc., Pfizer Inc., Ionis Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Celgene Corporation, Takeda Pharmaceutical Company Ltd., Johnson and Johnson Pvt. Ltd., GlaxoSmithKline plc, Alnylam Pharmaceuticals Inc., SOM Innovation Biotech S.L., AstraZeneca plc.

Amyloidosis Treatment Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Amyloidosis Treatment Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. 

1. Amyloidosis Treatment Market - Overview
        1.1 Definitions and Scope
2. Amyloidosis Treatment Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Amyloidosis Treatment Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Amyloidosis Treatment Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Amyloidosis Treatment Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Amyloidosis Treatment Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Amyloidosis Treatment Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Amyloidosis Treatment Market - By Product (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Amyloidosis Treatment Market - By Treatment (Market Size -$Million / $Billion)
9.1 Chemotherapy
9.2 Supportive Care
9.3 Surgery
9.4 Stem Cell Transplant (SCT)
9.5 Targeted Therapy
10. Amyloidosis Treatment - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. Amyloidosis Treatment- By Geography (Market Size -$Million / $Billion)
        11.1 Amyloidosis Treatment Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Amyloidosis Treatment- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Amyloidosis Treatment- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Amyloidosis Treatment - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Amyloidosis Treatment - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Amyloidosis Treatment Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Amyloidosis Treatment Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Amyloidosis Treatment Market - Key Company List by Country Premium
15. Amyloidosis Treatment Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Alnylam Pharmaceutical
        15.3 Ionis Pharmaceutical
        15.4 Johnson Johnson
        15.5 Pfizer
        15.6 Takeda
        15.7 Company 7
        15.8 Company 8 & More
*Financials would be provided on a best efforts basis for private companies
16. Amyloidosis Treatment Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Amyloidosis Treatment Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

List of Tables

1 US Amyloidosis Treatment Market Size 2018
2 Canada Amyloidosis Treatment Market Share 2018
3 Brazil Amyloidosis Treatment Market Outlook 2019 - 2023
4 Mexico Amyloidosis Treatment Market Research 2018
5 Germany Amyloidosis Treatment Market Trends 2019 - 2023 
6 France Amyloidosis Treatment Market Growth 2019 - 2023 
7 UK Amyloidosis Treatment Market Demand 2019 - 2023 
8 Italy Amyloidosis Treatment Market Segmentation 2018
9 Russia Amyloidosis Treatment Market Analysis 2019 - 2023
10 China Amyloidosis Treatment Market Revenue 2019 - 2023
11 Japan Amyloidosis Treatment Market Volume 2019 - 2023
12 South Korea Amyloidosis Treatment Market Potential 2019 - 2023
13 India Amyloidosis Treatment Market Leaders 2018
14 Saudi Arabia Amyloidosis Treatment Market Forecast 2019 - 2023 
15 Kuwait Amyloidosis Treatment Market Value 2018

List of Figures

For complete list of 60+ tables and 60+ figures follow the Link